EUVIMEDDescubrir EUVIMED
Crossref

Organosulfur Compounds, S ‐Allyl‐L‐Cysteine and S ‐Ethyl‐L‐Cysteine, Target PCSK ‐9/ LDL ‐R‐Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet‐Induced Metabolic Syndrome in Rats

Parvej Ahmad, Arunim Shah, Mohd Waiz, Chandra P Chaturvedi, Sahir Sultan Alvi iD, M Salman Khan

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8323 ↗

At a glance

Journal article in Phytotherapy Research, 2025. Written by Parvej Ahmad and 5 co-authors. Institution: Integral Information & Research Center (IIRC-5), Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University…. Major MEDLINE topics: Metabolic Syndrome, Proprotein Convertase 9, Cysteine, Receptors, LDL. Cited 6 times so far (Crossref); 73 references. Funded by: Young Scientist Award, Department of Health Research (DHR), Ministry of Health & Family Welfare (MoHFW), Government of India.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Metabolic syndrome (MetS) is an ever‐evolving set of diseases that poses a serious health risk in many countries worldwide. Existing evidence illustrates that individuals with MetS have a 30%–40% higher chance of acquiring type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), or both. This study was undertaken to uncover the regulatory role of natural organosulfur compounds (OSCs), S ‐allyl‐L‐cysteine (SAC), and S ‐ethyl‐L‐cysteine (SEC), in targeting high carbohydrate high fat (HCHF)‐diet‐induced MetS‐associated risk management. Our findings suggested that SAC and SEC ameliorated HCHF‐diet‐induced diabetic profiles, plasma lipid and lipoprotein level, liver function, oxidative‐stress, inflammatory cytokines, and chemokines including monocyte chemoattractant protein‐1 (MCP‐1), lipid peroxidation, plasma proprotein convertase subtilisin/kexin type‐9 (PCSK‐9), and high‐sensitivity C‐reactive protein (hs‐CRP). Moreover, the assessment of the hepatic mRNA expression of the key genes involved in cholesterol homeostasis depicted that SAC and SEC downregulated the PCSK‐9 mRNA expression via targeting the expression of HNF‐1α, a transcriptional activator of PCSK‐9. On the other hand, the LDL‐receptor (LDL‐R) expression was upregulated through the activation of its transcriptional regulator sterol regulatory element binding protein‐2 (SREBP‐2). In addition, the activity and the mRNA expression of 3‐hydroxy‐3‐methylglutaryl coenzyme‐A reductases (HMG‐R) and peroxisome proliferator‐activated receptors (PPARs) were also improved by the treatment of SAC and SEC. We concluded that SAC and SEC can protect against MetS via improving the lipid and lipoprotein content, glycemic indices, hepatic function, targeting the inflammatory cascades, and oxidative imbalance, regulation of the mRNA expression of PCSK‐9, LDL‐R, SREBP‐2, HNF‐1α, PPARs, and inflammatory biomarkers.

Subjects

MeSH terms (MEDLINE)

Metabolic SyndromeProprotein Convertase 9CysteineReceptors, LDLAnimalsDiet, High-FatLiverMaleRatsOxidative StressDietary CarbohydratesRats, Sprague-DawleyCardiovascular Diseases

Author keywords

PCSK‐9‐LDL‐R axisS‐Allyl‐L‐Cysteine and S‐Ethyl‐L‐Cysteinehigh carbohydrate high fat (HCHF)‐dietinflammationmetabolic syndromeorganosulfur compounds (OSCs)

Substances

S-allylcysteineProprotein Convertase 9CysteineReceptors, LDLPCSK9 protein, ratDietary Carbohydrates

Authors and institutions

  • Integral Information & Research Center (IIRC-5), Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, India.
  • Stem Cell Research Center, Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India.
  • Department of Medicine and Oncology ISU, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas, USA.
  • South Texas Center of Excellence for Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas, USA.
  • Department of Biotechnology, Era University, Lucknow, Uttar Pradesh, India.

ORCID profiles: Sahir Sultan Alvi

Funding

  • Young Scientist Award, Department of Health Research (DHR), Ministry of Health & Family Welfare (MoHFW), Government of India

Cite

APA

Ahmad, P., Shah, A., Waiz, M., Chaturvedi, C. P., Alvi, S. S., & Khan, M. S. (2025). Organosulfur Compounds, S ‐Allyl‐L‐Cysteine and S ‐Ethyl‐L‐Cysteine, Target PCSK ‐9/ LDL ‐R‐Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet‐Induced Metabolic Syndrome in Rats. Phytotherapy Research. https://doi.org/10.1002/ptr.8323

Vancouver

Ahmad P, Shah A, Waiz M, Chaturvedi CP, Alvi SS, Khan MS. Organosulfur Compounds, S ‐Allyl‐L‐Cysteine and S ‐Ethyl‐L‐Cysteine, Target PCSK ‐9/ LDL ‐R‐Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet‐Induced Metabolic Syndrome in Rats. Phytotherapy Research. 2025. doi:10.1002/ptr.8323

BibTeX
@article{Ahmad2025,
  author = {Ahmad, Parvej and Shah, Arunim and Waiz, Mohd and Chaturvedi, Chandra P and Alvi, Sahir Sultan and Khan, M Salman},
  title = {Organosulfur Compounds, S ‐Allyl‐L‐Cysteine and S ‐Ethyl‐L‐Cysteine, Target PCSK ‐9/ LDL ‐R‐Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet‐Induced Metabolic Syndrome in Rats},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8323}
}
Start for free →